Product description
What is GHK-Cu?
GHK-Cu is a naturally occurring tripeptide (a peptide composed of three amino acids: glycine, histidine, and lysine) that forms a stable complex with the copper ion (Cu²⁺). It was discovered in 1973 by Dr. Loren Pickart during research on human blood plasma, where it was observed that the albumin fraction from young donors stimulated liver cells from older donors to synthesize proteins characteristic of younger tissues.
GHK-Cu occurs naturally in human plasma, saliva, and urine. The concentration of this peptide in plasma changes with age – it is about 200 ng/ml at the age of 20 and falls to about 80 ng/ml at the age of 60. This decline correlates with the observed reduction in the body’s regenerative capacity, making GHK-Cu the subject of intensive research in the context of aging processes and tissue regeneration.
Mechanism of action
GHK-Cu is characterized by a unique mechanism of action that includes several interconnected molecular pathways:
Copper chelation – histidine in the peptide sequence forms a stable complex with the copper ion Cu²⁺. Copper is a cofactor for key enzymes, including lysyl oxidase (LOX), which is responsible for cross-linking collagen and elastin, and superoxide dismutase (SOD), which has antioxidant activity.
Modulation of gene expression – studies using the Connectivity Map (Broad Institute) have shown that GHK-Cu affects the expression of thousands of human genes. This peptide activates genes associated with DNA repair, extracellular matrix synthesis, and the antioxidant response, while simultaneously inhibiting pro-inflammatory genes.
Activation of signaling pathways – GHK-Cu interacts with integrin pathways (integrin α1β1), which affects cell adhesion, migration, and proliferation. The peptide also stimulates the TGF-β pathway involved in healing and tissue remodeling processes.
Antioxidant activity – GHK shows the ability to neutralize toxic products of lipid peroxidation, such as 4-hydroxynonenal (HNE) and acrolein, protecting cells against oxidative stress.
Directions of scientific research
GHK-Cu is the subject of extensive preclinical and clinical research. The main research areas include:
Research on skin regeneration and wound healing
Numerous in vitro and in vivo studies analyze the effect of GHK-Cu on wound healing processes. In animal models, accelerated wound contraction, increased angiogenesis, and stimulation of collagen synthesis have been observed. Studies on human fibroblasts showed increased production of type I and III collagen, elastin, and glycosaminoglycans. Hydrogel and nanoparticle formulations containing GHK-Cu, studied for applications in next-generation dressings, are of particular interest.
Dermatological and cosmetic studies
Clinical studies involving women aged around 50 years showed that the application of creams with GHK-Cu for 12 weeks affected skin density and thickness, reduction of fine wrinkles, and improvement in elasticity. Comparative clinical studies analyzed the effectiveness of GHK-Cu relative to vitamin C and retinoic acid in the context of stimulating collagen production.
Research on pulmonary fibrosis
In mouse models of bleomycin-induced pulmonary fibrosis, GHK showed the ability to reduce inflammatory cell infiltration, decrease interstitial tissue thickness, and lower levels of pro-inflammatory cytokines (TNF-α, IL-6). These studies suggest potential applications in the context of idiopathic pulmonary fibrosis through modulation of the TGF-β1/Smad pathway.
Research on fibroblast function
Studies on the effect of GHK-Cu on fibroblasts derived from patients with chronic obstructive pulmonary disease (COPD) are particularly interesting. Treatment with GHK restored the ability of these cells to contract and remodel collagen gel, suggesting potential in restoring the regenerative functions of damaged tissues.
Research on hair growth
Preclinical studies analyze the effect of GHK-Cu on hair follicles. This peptide stimulates the proliferation of dermal papilla cells and prolongs the anagen (growth) phase of the hair cycle. Work is underway on formulations for topical application in the context of androgenetic alopecia.
Neuroprotective research
Analyses of the gene expression profile indicate an effect of GHK on genes associated with neuronal function and DNA repair. In the context of neurodegenerative diseases, the potential of GHK-Cu as a regulator of copper homeostasis, disturbances of which are observed in Alzheimer’s disease, is being studied.
Scientific context
GHK-Cu belongs to the growing class of bioactive peptides studied in regenerative medicine. It stands out from other cosmetic peptides (such as Matrixyl or Argireline) due to its endogenous origin and broad profile of biological activity confirmed in molecular studies.
The stability of GHK-Cu is both an advantage (high stability in solutions) and a research challenge – the peptide is susceptible to degradation by carboxypeptidases present in wound fluids. For this reason, research is being conducted on advanced delivery systems, including nanoparticles, hydrogels, and conjugates with cell-penetrating peptides.
Safety profile in studies
In available preclinical and clinical studies, GHK-Cu is characterized by a favorable safety profile. No significant adverse effects have been reported in dermatological studies with topical application. The peptide is a natural component of the human body, which theoretically reduces the risk of immunological reactions.
However, it should be noted that excessive copper concentrations may lead to unfavorable effects, including increased activity of matrix metalloproteinases (MMP), which in excess may contribute to collagen degradation. Optimal dosing remains the subject of further research.
Bibliography – latest scientific research
- Adnan SB, Maarof M, Fauzi MB, Fadilah NIM. Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review. Int J Med Sci. 2025;22(16):4175-4200. PubMed
- Castro VIB, et al. Nanoengineered Self-Assembling Peptides with Increased Proteolytic Stability Promote Wound Healing. ACS Appl Mater Interfaces. 2025;17(8):11624-11633. PubMed
- He Q, Mazzola J, Ladiges W. The naturally occurring peptide GHK reverses age-related fibrosis by modulating myofibroblast function. Aging Pathobiol Ther. 2024;6(4):186-190. Link
- Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. BioImpacts. 2025;15:30071. PubMed
- Wang Y, Zheng Z, Pathak JL, et al. Food-Derived Tripeptide–Copper Self-Healing Hydrogel for Infected Wound Healing. Biomater Res. 2024. Link
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PMC
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. PMC
- Dou Y, Lee A, Zhu L, Morton J, Ladiges W. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2(1):58-61. PMC
- Pickart L, Margolina A. The Effect of the Human Plasma Molecule GHK-Cu on Stem Cell Actions and Expression of Relevant Genes. OBM Geriatrics. 2018;2(3):009. Link
- Pickart L, Margolina A. The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health. Oxid Med Cell Longev. 2012;2012:324832. PMC
